Registration Opening Soon for BOS Events 2025!

Dates for BOS Events 2025 are confirmed as 11th and 12th June for BOS Basel 2025 and 25th and 26th November for BOS Manchester 2025. Please find further details outlining provisional floor plans and pricing options at the event links provided. Note that we plan to open for registrations on Monday 4th November at 09.00 GMT.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Featured Company (BOS Manchester 2024)

CMC Innov
CMC Innov (www.cmcinnov.com) is a science-focused consulting company specializing in small molecule drug substance and drug product development. The company was created in 2023 on the solid foundations of 26 years’ experience in big pharma supporting small molecule and hydrogel dermal filler R&D projects...
View profile

Featured Speaker (BOS Manchester 2024)

Feasibility of Developing Topical Formulation: Concept to Advanced Clinical Phase

Yogeshwar Bachhav, Director (Consultant), AiCuris Anti-infective Cures AG

ABSTRACT: The topical route of administration, a crucial aspect in drug development, remains attractive to avoid unwarranted systemic exposure of the drugs. The development of a topical formulation for an investigational compound is a distinct challenge compared to other routes of administration, linked to the drug's physicochemical properties and dose. This topic is of significant importance and will be explored in detail in the upcoming presentation.

In his presentation at BOS Manchester 2024, Dr. Yogeshwar Bachhav, a seasoned Director and Consultant at AiCuris Anti-infective Cures AG, Germany,... Click here to Read More